de Leon J, Woods A, Twentyman T, Meade M, Sproule V, Chandran S, Christiansen J, Kennedy N, Marney M, Barooshian K, Plit M, Lynch J, Jagavkar R, Ormandy H, Christodouleas J, Pietzsch F, Chan M, Jameson MG. Analysis of data to Advance Personalised Therapy with MR-Linac (ADAPT-MRL).
Clin Transl Radiat Oncol 2021;
31:64-70. [PMID:
34646950 PMCID:
PMC8495756 DOI:
10.1016/j.ctro.2021.09.004]
[Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/15/2021] [Accepted: 09/08/2021] [Indexed: 12/03/2022] Open
Abstract
BACKGROUND
Analysis of Data to Advance Personalised Therapy with MR-Linac (ADAPT-MRL) is a multi-site, multinational, observational cohort registry designed to collect data on the use of the magnetic resonance linear accelerator (MR-Linac) for radiation therapy and patient outcomes. The registry will provide a linked repository of technical and clinical data that will form a platform for prospective studies and technology assessment.
METHODS
Design: This registry aims to include an estimated 10,000 eligible participants across Australia and other countries over a 7- to 10-year period. Participants will undergo treatment and assessments in accordance with standard practice. Toxicity and survival outcomes will be assessed at baseline, during treatment, and with 3 monthly follow-up until 24 months, patient reported outcome measures will also be collected. Participants with a variety of cancers will be included.
DISCUSSION
Data obtained from the ADAPT-MRL registry is expected to provide evidence on the safety and efficacy of the MR-Linac, a new technical innovation in radiation oncology. We expect this registry will generate data that will be used to optimise treatment techniques, MR-Linac software algorithms, evaluate participants' outcomes and toxicities and to create a repository of adapted plans, anatomical and functional MR sequences linked to participants' outcomes.
Collapse